MedPath

Evaluation of Efficacy of Full-mouth Disinfection in Generalized Aggressive Periodontitis Patients

Phase 4
Completed
Conditions
Aggressive Periodontitis
Interventions
Drug: Klorhex® Gel, rinse and spray
Procedure: Conventional IPT
Procedure: Full-mouth IPT
Registration Number
NCT02466646
Lead Sponsor
Marmara University
Brief Summary

The purpose of this study is to determine whether full-mouth disinfection is effective in the initial periodontal treatment of generalized aggressive periodontitis on clinical parameters, gingival crevicular fluid interleukin-1β (IL-1β) and interleukin-17 (IL-17) and periodontal pathogen levels compared with conventional initial periodontal treatment and full-mouth initial periodontal treatment.

The investigators' hypothesis is to test whether full-mouth disinfection in the initial periodontal treatment of generalized aggressive periodontitis enhance the clinical, biochemical and microbiological parameters in comparison to conventional initial periodontal treatment and full-mouth initial periodontal treatment.

Detailed Description

The present study aimed to compare the efficacy of conventional initial periodontal treatment (C-IPT), full-mouth disinfection IPT (FMD-IPT) and full-mouth IPT (FM-IPT) and the levels of gingival crevicular fluid interleukin-1β (IL-1β) and interleukin-17 (IL-17), Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Fusobacterium nucleatum, Prevotella intermedia, Parvimonas micra and Campylobacter rectus in patients with generalized aggressive periodontitis (GAgP) over 6-months period. Forty-two GAgP patients were randomly assigned into 3 groups. IPT was performed in a quadrant-wise manner at 1-week intervals in C-IPT, in 2 sessions within 24 hours in FM-IPT, and in 2 sessions with application of chlorhexidine to the intra-oral niches within 24 hours in FMD-IPT. FMD-IPT group also used daily 0,2% chlorhexidine for 3 weeks. At baseline, 3 and 6 months clinical parameters consisting of plaque index, gingival index, probing depth, bleeding on probing and clinical attachment level were recorded, gingival crevicular fluid and microbiological samples were collected. Gingival crevicular fluid levels of IL-1β and IL-17 were analyzed using ELISA. The quantitative real-time polymerase chain reaction method was used for the quantitative detection of periodontal pathogens.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • No systemic diseases that could influence the outcome of the therapy
  • No smoking
  • No medications affecting periodontal tissues
  • No pregnancy or lactation
  • Presence of at least 15 teeth
Exclusion Criteria
  • Received antibiotic treatment in the previous 3 months
  • Smokers
  • Pregnancy and lactation
  • Received periodontal treatment in the previous 6 months
  • Presence of less than 15 teeth
  • Presence of systemic diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Full-mouth Disinfection IPTKlorhex® Gel, rinse and sprayInitial periodontal treatment was performed in 2 sessions with application of chlorhexidine to the intra-oral niches within 24 hours (Klorhex® Gel 1% for 10 minutes, Klorhex® Spray 0,2% and Klorhex® rinse 0,2% for 3 weeks).
Conventional IPTConventional IPTInitial periodontal treatment was performed in a quadrant-wise manner at 1-week intervals.
Full-mouth IPTFull-mouth IPTInitial periodontal treatment was performed in 2 sessions within 24 hours.
Primary Outcome Measures
NameTimeMethod
Probing Depth6 months after initial periodontal treatment
Secondary Outcome Measures
NameTimeMethod
Bleeding on ProbingBaseline, 3 and 6 months after initial periodontal treatment

Possible score for BOP range from %0 (no sites with bleeding on probing) to %100 (all sites with bleeding on probing). Higher scores mean worse outcome.

Gingival IndexBaseline, 3 and 6 months after initial periodontal treatment

Possible score for Gingival Index range from 0 (healthy gingiva) to 3 (severe gingivitis with bleeding). Higher scores mean worse outcome

Clinical Attachment LevelBaseline, 3 and 6 months after initial periodontal treatment
Level of Porphyromonas GingivalisBaseline, 3 and 6 months after initial periodontal treatment
Level of A. ActinomycetemcomitansBaseline, 3 and 6 months after initial periodontal treatment
Level of Prevotella IntermediaBaseline, 3 and 6 months after initial periodontal treatment
Level of Campylobacter RectusBaseline, 3 and 6 months after initial periodontal treatment
Gingival Crevicular Fluid Interleukin-1β and Interleukin-17 Levels (pg)Baseline, 3 and 6 months after initial periodontal treatment
Level of Fusobacterium NucleatumBaseline, 3 and 6 months after initial periodontal treatment
Level of Parvimonas MicraBaseline, 3 and 6 months after initial periodontal treatment
Plaque IndexBaseline, 3 and 6 months after initial periodontal treatment

Possible scores for Plaque Index range from 0 (no plaque) to 3 (visible plaque all around the tooth). Higher scores mean a worse outcome

© Copyright 2025. All Rights Reserved by MedPath